Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
Liu GY, Ye YF, Jiang YF, Chen GJ, Xia WX, Huang YS, Gao TS, Liu YM, Hou YT, Li JF, Liu JH, Lu N, Chen CL, Ke LR, Liang H, Bei WX, Li WZ, Dong SH, Liu Q, Xie C, Yao HR, Xiang YQ.
Liu GY, et al. Among authors: hou yt.
BMJ. 2024 Jun 19;385:e077890. doi: 10.1136/bmj-2023-077890.
BMJ. 2024.
PMID: 38897625
Free PMC article.
Clinical Trial.